The Sexual Ethics of HPV Vaccination for Boys
Human papillomavirus (HPV) is one of the most common sexually transmitted infections. It is a leading cause of cervical cancer in women but the virus is increasingly being linked to several other cancers in men and women alike. Since the introduction of safe and effective but also expensive vaccines, many developed countries have implemented selective vaccination programs for girls. Some however argue that these programs should be expanded to include boys, since (1) HPV constitutes non-negligible health risks for boys as well and (2) protected boys will indirectly also protect girls. In this paper we approach this discussion from an ethical perspective. First, on which moral grounds can one justify not reimbursing vaccination for the male sex? We develop an ethical framework to evaluate selective vaccination programs and conclude that, in the case of HPV, efficiency needs to be balanced against non-stigmatization, non-discrimination and justice. Second, if vaccination programs were to be expanded to boys as well, do the latter then also have a moral duty to become immunized? Two arguments in favor of such a moral duty are well known in vaccination ethics: the duty not to harm others and to contribute to the public good of public health. However, we argue that these are not particularly convincing in the context of HPV. In contrast, we believe a third, more powerful but also more controversial argument is possible. In our view, the sexual mode of transmission of HPV constitutes an additional reason to believe that boys in fact may have a moral obligation to accept vaccination.
KeywordsInfectious disease Public health Immunization Efficiency Sexually transmitted infection HPV
- Ali, H., Guy, R. J., Wand, H., Read, T. R., Regan, D. G., Grulich, A. E., Fairley, C. K., Donovan, B. (2013). Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infectious Disease, 13, 140. doi: 10.1186/1471-2334-13-140.
- Beauchamp, T., & Childress, J. (2001). Principles of biomedical ethics (5th ed.). Oxford: Oxford University Press.Google Scholar
- Burls, A., Jordan, R., Barton, P., Olowokure, B., Wake, B., Albon, E., et al. (2006). Vaccinating healthcare workers against influenza to protect the vulnerable—Is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine, 24(19), 4212–4221. doi: 10.1016/j.vaccine.2005.12.043.CrossRefGoogle Scholar
- Daniels, N., Kennedy, B., & Kawachi, I. (2000). justice Is good for our health: How greater economic equality would promote public health. Boston Review, 25(1), 4–19.Google Scholar
- Dawson, A. (2009). Herd protection as a public good: Vaccination and our obligations to others. In A. Dawson & M. Verweij (Eds.), Ethics, prevention and public health. Oxford: Oxford University Press.Google Scholar
- Ed. (2013). GAVI injects new life into HPV vaccine rollout. The Lancet, 381(9879), 1688.Google Scholar
- Judd, A., Hickman, M., Hope, V. D., Sutton, A. J., Stimson, G. V., Ramsay, M. E., Gill, O. N., Parry, J. V. (2007). Twenty years of selective hepatitis B vaccination: Is hepatitis B declining among injecting drug users in England and Wales? Journal of Viral Hepatitis, 14(8), 584–591. doi: 10.1111/j.1365-2893.2007.00844.x.Google Scholar
- Lefevere, E., Hens, N., Theeten, H., Van den Bosch, K., Beutels, P., De Smet, F., et al. (2011). Like mother, like daughter? Mother’s history of cervical cancer screening and daughter’s Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine, 29(46), 8390–8396. doi: 10.1016/j.vaccine.2011.08.039.CrossRefGoogle Scholar
- Mill, J. S. (1869). On liberty. London: Longman, Roberts & Green.Google Scholar
- Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V.,Snijders, P. J., & Meijer, C. J. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine, 348(6), 518–527. doi: 10.1056/NEJMoa021641.
- Parkin, D. M., & Bray, F. (2006). Chapter 2: The burden of HPV-related cancers. Vaccine, 24(Suppl 3), S3/11–S3/25. doi: 10.1016/j.vaccine.2006.05.111.
- Postma, M. J., Bos, J. M., Beutels, P., Schilthuis, H., & van den Hoek, J. A. (2004). Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Vaccine, 22(15–16), 1862–1867. doi: 10.1016/j.vaccine.2003.11.012.CrossRefGoogle Scholar
- Salo, H., Leino, T., Kilpi, T., Auranen, K., Tiihonen, P., Lehtinen, M.,…,Nieminen, P. (2013). The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland. International Journal of Cancer. doi: 10.1002/ijc.28145.
- Slote, M. (2000). Virtue ethics. In H. Lafollette (Ed.), The Blackwell guide to ethical theory (pp. 325–347). Malden, MA: Blackwell.Google Scholar
- Thaler, R. H., & Sunstein, C. (2008). Nudge: Improving decisions about health, wealth and happiness. New Haven, NJ: Yale University Press.Google Scholar
- Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. The Lancet, 357(9267), 1513–1518. doi: 10.1016/S0140-6736(00)04638-9.
- Wu, X., Watson, M., Wilson, R., Saraiya, M., Cleveland, J., & Markowitz, L. (2012). Human papillomavirus-associated cancers—United States, 2004–2008. Morbidity and Mortality Weekly Report of Centers for Disease Control and Prevention, 61(15), 258–261.Google Scholar